期刊文献+

VEGF-D及Ki-67在乳腺癌淋巴结转移中的作用 被引量:2

The significance of VEGF-D/Ki-67 expression in breast cancer lymph vessel metastasis.
下载PDF
导出
摘要 目的探讨VEGF-D及Ki-67在乳腺癌淋巴结转移中的作用和意义。方法采用免疫组化二步法检测90例乳腺癌组织中VEGF-D和Ki-67的表达。结果①VEGF-D阳性率在淋巴结转移组为82%(41/50),显著高于未转移淋巴组37.5%(15/40),(P<0.01)。Ki-67阳性率在淋巴结转移组为84%(42/50),显著高于未转移淋巴组42.5%(17/40),(P<0.05),且VEGF-D与Ki-67的表达显著相关(P<0.05);②VEGF-D的表达与年龄、肿瘤大小、病理分型、临床分级、ER、PR无关,与CerbB-2表达显著相关(P<0.05)。Ki-67的表达与年龄、肿瘤大小无相关性(P>0.05),而与肿瘤组织分级、淋巴结转移有显著相关性(P<0.05)。结论 VEGF-D和Ki-67的表达与乳腺癌淋巴结转移有关,可能促进了乳腺癌淋巴管的生成和增殖。 Objective To study the effects and significance of VEGF-D/Ki-67 expression in breast cancer lymph vessel metastasis.Methods Two-stcps immunobistochemiscal staining was used to detect the expression of VEGF-D/Ki-67 in 90 cases of breast cancer.Results ①The positive rate of VEGF-D,82%(41/50)in lymph node metastasis group,was significantly higher than that,37.5%(15/40),in no lymph node metastsis group(P0.01).The positive rate of Ki-67,84%(42/50),in lymph node metastasis group,was significantly higher than that,42.5%(17/40).in no lymph node metastsis group(P0.05),and significant correlation was found between the expression of VEGF-D and Ki-67(P0.05);②There was no correlation between the expression of VEGF-D and age,tumor size,pathology,grade,ER and PR.but significant correlation with CerbB-2(P0.05).There was no correlation between the expression of Ki-67 and age,tumor size(P0.05),but there was relation between the expression of Ki-67 and pathology,grade,lymph node metastsis(P0.05).Conclusion The expression of VEGF-D and Ki-67 is significantly correlated with breast cancer lymph vessel metastasis and maybe promote lymphangiogenesis of breast cancer.
出处 《四川医学》 CAS 2010年第6期714-716,共3页 Sichuan Medical Journal
关键词 乳腺癌 VEGF-D KI-67 淋巴结转移 breast cancer VEGF-D Ki-67 lymph vessel metastasis
  • 相关文献

参考文献4

二级参考文献56

  • 1汤红平,张雅洁,顾莹莹,张惠球.VEGF-C和VEGF-D在乳腺癌中的表达及其作用[J].肿瘤,2006,26(6):551-554. 被引量:18
  • 2赵国光,向晓娟,何友兼.血管内皮生长因子C、D在鼻咽癌组织中的表达及其临床意义[J].癌症,2007,26(1):90-95. 被引量:22
  • 3刘尚廉.乳腺癌雌激素受体的酶联雌二醇组化检验法[J].肿瘤,1998,3(2):104-104.
  • 4Salameh A, Galvagni F, Bardelli M, et al. Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways [J]. Blood, 2005,106(10) : 3423 -3431.
  • 5Achen MG, Jeltsch M, Kukk E, et al. Vascular endothelial growth factor (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk 1 ) and VEGF receptor 3 (Fit 4)[J]. Proc Natl Acad Sci U S A, 1998,95(2): 548-553.
  • 6Stacker SA, Stenvers K, Caesar C, et al. Biosynthesis of vascular endothelial growth faetor-D involves proteolytic processing which generates non- covalent homodimers[J]. J Biol Chem, 1999,274(45) : 32127-32136.
  • 7Achen MG, Williams RA, Baldwin ME, et al. The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer [ J ]. Growth Factors, 2002,20 (2) : 99-107.
  • 8Akahane M, Akahane T, Shah A, et al. A potential role for vascular endothelial growth factor-D as an autocrine growth factor for human breast carcinoma cells [J]. Anticancer Res, 2005,25(2A):701-707.
  • 9Mylona E, Alexandrou P, Mpakali A, et al. Clinicopathologieal and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma [J]. Eur J Surg Oncol, 2007,33 ( 3 ) : 294-300.
  • 10van der Schaft DW, Pauwels P, Hulsmans S, et al. Absence of lymphangiogenesis in ductaI breast cancer at the primary tumor site [J]. Cancer Lett, 2007,254( 1 ) : 128-136.

共引文献40

同被引文献21

  • 1Da MX,Wu XT,Wang J,et al.Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer.Arch Med Res,2008,39:92-99.
  • 2Nakamura Y,Yasuoka H,Tsujimoto,et al.lymph vessel density correlates with nodal status,VEGF-C expression,and prognosis in breast cancer.Breast cancer Res Treat 2005,91:125-132.
  • 3Mylona E,Alexandrou P,Mpakali A,et al.Clinicopathological and prognostic significance of vascular endothelial growth factors(VEGF)-C and-D and VEGF receptor 3 in invasive breast carcinoma.Eur J Surg Oncol,2007,33:294-300.
  • 4Timoshenko AV,Chakraborty C,Wagner GF,et al.COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer.Br J Cancer,2006,94:2254-1163.
  • 5Linderholm BK,Hellborg H,Johhanson U,et al.Significantly higher levels of vascular endothelial factor(VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer.Ann Oncol,2009,20:1639-1646.
  • 6Mandriota SJ,Jussila L,Jeltsch M,et al.Vascular endothelial growth factor-C mediated lymphangiogenesis promotes tumour metastasis.EMBO J,2001,20:672-682.
  • 7Karpanen T,Heckman CA,Keskitalo S,et al.functional interaction of VEGF-C and VEGF-D with neuropilin receptors.FASEB J,2006,20:1462-1472.
  • 8Su JL,Yen CJ,Chen PS,et al.The role of the VEGF-C/VEGFR-3 axis in caner progression.Br J Cancer,2007,96:541-545.
  • 9Kaparnen T,Aliatlo K.Lymphatic vessels as targets of tumor therapy?J Ex P Med,2001,194:F37-F42.
  • 10Timoshenko AV,Rastogi S,Lala PK.Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.Br J Cancer,2007,97:1090-1098.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部